-
Recent Posts
Receive Our New Post Alert!
Subscribe to receive happy little notifications whenever there is a new blog post on mmmbitesizescience. Subscribe to our notificationsArchives
- July 2020
- July 2017
- August 2016
- December 2015
- February 2015
- December 2014
- November 2014
- September 2014
- July 2014
- June 2014
- May 2014
- April 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
Top Posts & Pages
Categories
- Analgesics
- Archaeology
- Bacteria
- Bioengineering
- Cancer Immunotherapy
- Conservation
- Disease
- Ecology
- Evolution
- Fungi
- Genetics
- Health
- Immunology
- Immunotherapy
- Marine
- Medicine
- Microorganisms
- Mutations
- Neuroscience
- Obesity
- Oncolytic Virus
- Parasites
- Personalised Medicine
- Plants
- Reproducibility
- Reproduction
- Science
- Science Policy
- Space
- systematic review
- The Environment
- Uncategorized
- Vaccines
- Virology
- Viruses
Support this SCIENCE blog!
Meta
Category Archives: Personalised Medicine
Two Cancer Immunotherapy Targets are Better Than One
In cancer patients undergoing adoptive T cell therapy, T cells that recognise and react to an abundant protein fragment expressed by a tumour cell are infused into the bloodstream. These protein fragments are known as tumour-associated antigens. Because cancers are … Continue reading
Using Viruses to Tune T Cell Functionality
As we have learned more about the world of microbes, it’s become clear that it’s possible to use bacteria and viruses as treatments against disease. But although microbes often work incredibly well at protecting against infections or attacking tumours, we … Continue reading
From tumour biopsy to personalised cancer treatment in 16 days
Every cancer patient essentially has a unique genetic disease. While certain key ‘driver’ mutations in genes such as TP53 and KRAS are almost always present, many other ‘passenger’ mutations are collected as tumours evolve that shape their genetic footprint. These … Continue reading